Centiva Capital’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,959
| Closed | -$96.2K | – | 1644 |
|
|
2024
Q4 | $96.2K | Buy |
+11,959
| New | +$96.2K | ﹤0.01% | 1156 |
|
|
2023
Q1 | – | Sell |
-67
| Closed | -$689 | – | 1268 |
|
|
2022
Q4 | $689 | Sell |
67
-41,686
| -100% | -$429K | ﹤0.01% | 904 |
|
|
2022
Q3 | $760K | Sell |
41,753
-6,344
| -13% | -$115K | 0.01% | 412 |
|
|
2022
Q2 | $2.47M | Buy |
48,097
+7,487
| +18% | +$385K | 0.06% | 173 |
|
|
2022
Q1 | $2.99M | Buy |
40,610
+14,632
| +56% | +$1.08M | 0.06% | 135 |
|
|
2021
Q4 | $3.72M | Buy |
25,978
+13,477
| +108% | +$1.93M | 0.08% | 88 |
|
|
2021
Q3 | $2.59M | Buy |
12,501
+291
| +2% | +$60.3K | 0.16% | 110 |
|
|
2021
Q2 | $2.59M | Buy |
12,210
+10,940
| +861% | +$2.32M | 0.06% | 102 |
|
|
2021
Q1 | $230K | Buy |
+1,270
| New | +$230K | 0.01% | 709 |
|